v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (32,367) $ (14,154)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 14,796 14,878
Amortization of debt issuance costs 252 443
Amortization of debt discount (1,433) 0
Provision for doubtful accounts 372 384
Gain on sale of BMI 0 (14,846)
Deferred income taxes 1,414 1,286
Stock-based compensation expense 849 1,072
Non-cash interest expense on financing liabilities 930 975
Non-cash imputed rental income (1,256) (1,222)
Changes in assets and liabilities (excluding acquisitions and dispositions):    
Accounts receivable 9,579 9,884
Trade receivable 428 (894)
Prepaid expenses and other current assets (3,726) (11,044)
Operating leases, net 117 (412)
Other assets 2,790 1,658
Accounts payable and accrued expenses 3,337 (4,454)
Trade payable 228 747
Other liabilities (134) (408)
Net cash used in operating activities (3,824) (16,107)
Cash flows from investing activities:    
Proceeds from sale of assets or stations 482 56
Proceeds from sale of BMI 0 14,846
Capital expenditures (5,540) (8,166)
Net cash (used in) provided by investing activities (5,058) 6,736
Cash flows from financing activities:    
Shares returned in lieu of tax payments (274) (1,084)
Repayments of financing liabilities (1,707) (1,607)
Repayments of finance lease obligations (279) (259)
Net cash used in financing activities (2,260) (2,950)
Decrease in cash and cash equivalents (11,142) (12,321)
Cash and cash equivalents at beginning of period 63,836 80,660
Cash and cash equivalents at end of period $ 52,694 $ 68,339